Shenzhen - Delayed Quote
CNY
Teyi Pharmaceutical Group Co.,Ltd (002728.SZ)
8.70
+0.15
(+1.75%)
At close: October 30 at 3:04:21 PM GMT+8
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. Xiliang Chen
|
CFO, Deputy GM & Director | -- | -- | 1972 |
|
Mr. Yongzhao Zhang
|
Deputy General Manager | -- | -- | 1982 |
|
Mr. Wei Cheng Wu
|
Deputy General Manager | -- | -- | 1969 |
|
Mr. Wen Ge Yan
|
Deputy General Manager | -- | -- | 1966 |
|
Bi Jian Cai
|
Accounting Supervisor | -- | -- | -- |
Teyi Pharmaceutical Group Co.,Ltd
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 1,434
Description
Teyi Pharmaceutical Group Co.,Ltd engages in the research and development, production, and sale of Chinese patented medicines, pharmaceutical preparations, raw materials, and products in the People's Republic of China. The company's products are used in respiratory system, cardiovascular and cerebrovascular, respiratory, cardiovascular, and digestive systems. The company was formerly known as Guangdong Taicheng Pharmaceutical Co., Ltd. and changed its name to Teyi Pharmaceutical Group Co.,Ltd in November 2016. The company was founded in 2002 and is based in Taishan, the People's Republic of China.
Corporate Governance
Teyi Pharmaceutical Group Co.,Ltd’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of
Institutional Shareholder Services (ISS)
Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
June 18, 2026 at 12:00 AM UTC
Ex-Dividend Date
